A nanoemulsion of an anti-oxidant synergy formulation reduces tumor growth rate in neuroblastoma-bearing nude mice

Journal of Experimental Therapeutics and Oncology

Volumn 6, Issue 2, 2007, Pages 129-135

  Kuo, Fonghsu ^a   Kotyla, Timothy ^a   Wilson, Thomas ^a   Kifle, Lydia ^b   Panagiotou, Thomai ^c   Gruverman, Irwin ^c   Tagne, Jean Bosco ^a   Shea, Thomas ^b   Nicolosi, Robert J ^a,d  

^a Center for Health and Disease Research   (United States)

^b University of Massachusetts Lowell   (United States)

^c Microfluidics   (United States)

^d UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN E; PHOSPHATIDYLCHOLINE; PYRUVATE SODIUM; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CHILDHOOD CANCER; CONTROLLED STUDY; DRUG FORMULATION; EMULSION; MOUSE; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; NUDE MOUSE; OXIDATIVE STRESS; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR MODEL; TUMOR XENOGRAFT;

ANIMALS; ANTIOXIDANTS; CHEMISTRY, PHARMACEUTICAL; DRUG SYNERGISM; EMULSIONS; MICE; NANOSTRUCTURES; NEUROBLASTOMA; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; PYRUVIC ACID; SUSPENSIONS; VITAMIN E;

EID: 33947423011     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bolande RP: The neurocristopathies: A unifying concept of disease arising in neuroal crest maldevelopment. Hum Pathol 5:409-429, 1974.
2. de Ruijter AJ, Kemp S, Kramer G, Meinsma RJ, Kaufmann JO, Caron HN, van Kuilenburg AB: The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells. Biochem Pharmacol 68(7):1279-1288, 2004.
3. Banelli B, Casciano I, Croce M, Di Vinci A, Gelvi I, Pagnan G, Brignole C, Allemanni G, Ferrini S, Ponzoni M et al.: Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. Nat Med 8(12): 1333-1335; author reply 1335, 2002.
4. Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411 (6835):342-348, 2001.
5. Kumar B, Hanson AJ, Prasad KN: Sensitivity of proteasome to its inhibitors increases during cAMP-induced differentiation of neuroblastoma cells in culture and causes decreased viability. Cancer Lett 204(1):53-59, 2004.
6. Turco A, Scarpa S, Coppa A, Baccheschi G, Palumbo C, Leonetti C, Zupi G, Colletta G: Increased TGFbeta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells. Exp Cell Res 255(1):77-85, 2000.
7. Yang KD, Chuen HL, Shaio MF: Pentoxifylline augments but does not antagonize TNF alpha-mediated neuroblastoma cell differentiation: modulation of calcium mobilization but not cAMP. Biochem Biophys Res Commun 211(3): 1006-1014, 1995.
8. Martin A: The use of antioxidants in healing. Dermatol Surg 22(2): 156-160, 1996.
9. Sheridan J, Kern E, Martin A, Booth A: Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections. Antiviral Res 36(3): 157-166, 1997.
10. Bauer G, O'Connell S, Devereux D, Martin A: Reversal of doxorubicin-impaired wound healing using triad compound. Am Surg 60 (6):455-459, 1994.
11. Shea TB, Ekinci FJ, Ortiz D, Dawn-Linsley M, Wilson TO, Nicolosi RJ: Efficacy of vitamin E, phosphatidyl choline, and pyruvate on buffering neuronal degeneration and oxidative stress in cultured cortical neurons and in central nervous tissue of apolipoprotein E-deficient mice. Free Radic Biol Med 33(2):276-282, 2002.
12. Hancock AL NE, Nicolosi RJ and Shea TB: An antioxidant formulation that induces differentiation of neuroblastoma in culture. Neurosci Res Commun 33:73-76, 2003.
13. Shea TB, Rogers E.: Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice:augmentation by vitamin E. Molecular Brain Research 108:1-6, 2002.
14. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A: The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 76(4):703-716, 2002.
15. Jagtap JC, Chandele A, Chopde BA, Shastry P: Sodium pyruvate protects against H(2)O(2) mediated apoptosis in human neuroblastoma cell line-SK-N-MC. J Chem Neuroanat 26(2):109-118, 2003.
16. P. Becher: Encyclopedia of Emulsion Technology. Marcel Deckker, New York 1: 129-285, 1983.
17. M. Porrasa, C. Solansb, C. Gonzáleza, A. Martýneza, A. Guinarta, J.M. Gutierreza: Studies of formation of W/O nanoemulsions. - Colloids and Surfaces A: Physicochem Eng Aspects 249:115-118, 2004.
18. Sonneville-Aubrun O, Simonnet JT, L'Alloret F: Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci 108-109:145-149, 2004.
19. Tadros T, Izquierdo P, Esquena J, Solans C: Formation and stability of nano-emulsions. Adv Colloid Interface Sci 108-109:303-318, 2004.
20. Constantinides PP, Tustian A, Kessler DR: Tocol emulsions for drug solubilization and parenteral delivery. Adv Drug Deliv Rev 56(9):1243-1255, 2004.
21. Kumar R, Chen MH, Parmar VS, Samuelson LA, Kumar J, Nicolosi R, Yoganathan S, Watterson AC: Supramolecular assemblies based on copolymers of PEG600 and functionalized aromatic diesters for drug delivery applications. J Am Chem Soc 126:10640-10644, 2004.
22. Van P, Zheng JM, Zhao HY, Li YJ, Xu H, Wei G: Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres. Acta Pharmacol Sin 23(11):1051-1056, 2002.
23. Vila A, Sanchez A, Evora C, Soriano I, McCallion O, Alonso MJ: PLA-PEG particles as nasal protein carriers: the influence of the particle size. Int J Pharm 292(1-2):43-52, 2005.
24. Thanos CG: Improving relative bioavailability of Dicumarol by reducing particle size and adding the adhesive Poly(Fumaric-Co-Sebacic) Anhydride. Pharmaceutical Research 20(7): 1093-1100, 2003.
25. de Smidt PC, M.A. Campanero, and I.F. Troconiz: Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int J Pharm 270((1-2)):109-118, 2004.
26. Cheng L, Hostetler KY, Lee J, Koh HJ, Beadle JR, Bessho K, Toyoguchi M, Aldern K, Bovet JM, Freeman WR: Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Invest Ophthalmol Vis Sci 45(11):4138-4144, 2004.
27. U.S. Patent # 6861066 Method for the delivery of a biologically active agent. March 1, 2005.
28. Crispens CG, Jr., Sorenson JR: Treatment of reticulum cell sarcoma in SJL/J mice with Tween 80. Anticancer Res 8(6):1341-1343, 1988.
29. Sporn MB, Suh N: Chemoprevention of cancer. Carcinogenesis, 21(3):525-530, 2000.
30. Welsch CW: Enhancement of mammary tumorigenesis by dietary fat; review of potential mechanisms. Am J Clin Nutr 45:192-202, 1987.
31. Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, Walborg EF, Jr.: The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106 Suppl 1:289-295, 1998.
32. Lee IM: Antioxidant vitamins in the prevention of cancer. Proc Assoc Am Physicians 111(1):10-15, 1999.
33. Moore SR, Hill KA, Heinmoller PW, Halangoda A, Kunishige M, Buettner VL, Graham KS, Sommer SS: Spontaneous mutation frequency and pattern in Big Blue mice fed a vitamin E-supplemented diet. Environ Mol Mutagen 34(2-3):195-200, 1999.
34. Azzi A, Boscoboinik D, Marilley D, Ozer NK, Stauble B, Tasinato A: Vitamin E: a sensor and an information transducer of the cell oxidation state. Am J Clin Nutr 62(6 Suppl): 1337S-1346S, 1995.
35. Ohshima H, Bereziat JC, Bartsch H: Monitoring N-nitrosamino acids excreted in the urine and feces of rats as an index for endogenous nitrosation. Carcinogenesis 3(1):115-120, 1982.
36. Kline, K and Sanders B.C.: Anti-tumor proliferation properties of vitamin E. Vitamins and Minerals in the Prevention and Treatment of Cancer: 189-205, 1991.
37. Singh U, Devaraj S, Jialal I: Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 25:151-174, 2005.
38. Singh U, Jialal I: Anti-inflammatory effects of alpha-tocopherol. Ann N Y Acad Sci 1031:195-203, 2004.
39. Grammas P, Hamdheydari L, Benaksas EJ, Mou S, Pye QN, Wechter WJ, Floyd RA, Stewart C, Hensley K: Anti-inflammatory effects of tocopherol metabolites. Biochem Biophys Res Commun 319(3): 1047-1052, 2004.
40. Johnsen JI, Lindskog M, Ponthan F, Pettersen I, Elfman L, Orrego A, Sveinbjornsson B, Kogner P: NSAIDs in neuroblastoma therapy. Cancer Lett 228(1-2): 195-201. 2005.
41. Mongan PD, Karaian J, Van Der Schuur BM, Via DK, Sharma P: Pyruvate prevents poly-ADP ribose polymerase (PARP) activation, oxidative damage, and pyruvate dehydrogenase deactivation during hemorrhagic shock in swine. J Surg Res 112(2): 180-188, 2003.